-
JUNS Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Jupiter Neurosciences (JUNS)
Company Profile
Quarter (USD) | Sep 24 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jan 25 | Allison W Brady | Common Stock, par value $0.0001 per share | Option exercise | Acquire M | No | No | 0 | 21,750 | 0.00 | 21,750 |
22 Jan 25 | Holger Weis | Common Stock, par value $0.0001 per share | Option exercise | Acquire M | No | No | 0 | 10,781 | 0.00 | 10,781 |